Evidence map›Paper›PMID 27558234›Full record

ArticleLife sciences2016

Nox4 contributes to the hypoxia-mediated regulation of actin cytoskeleton in cerebrovascular smooth muscle.

Maha Coucha, Mohammed Abdelsaid, Weiguo Li, Maribeth H Johnson, Laszlo Orfi, Azza B El-Remessy, Susan C Fagan, Adviye Ergul

Abstract read
In one paragraph

Article in Life sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Microvascular NADPH oxidase in health and disease.Free radical biology & medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Maha CouchaCharlie Norwood VA Medical Center, Augusta University, United States; Departments of Physiology, Augusta University, United States; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States.
Mohammed AbdelsaidCharlie Norwood VA Medical Center, Augusta University, United States; Departments of Physiology, Augusta University, United States.
Weiguo LiCharlie Norwood VA Medical Center, Augusta University, United States; Departments of Physiology, Augusta University, United States.
Maribeth H JohnsonDepartments of Biostatistics, Augusta University, United States.
Laszlo OrfiVichem Chemie, Ltd., Budapest, Hungary.
Azza B El-RemessyCharlie Norwood VA Medical Center, Augusta University, United States; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States.
Susan C FaganCharlie Norwood VA Medical Center, Augusta University, United States; Departments of Neurology, Augusta University, United States; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States.
Adviye ErgulCharlie Norwood VA Medical Center, Augusta University, United States; Departments of Physiology, Augusta University, United States; Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, United States. Electronic address: aergul@augusta.edu.
Augusta University · USCharlie Norwood VA Medical Center · USVichem Chemie (Hungary) · HU

Funding

Vascular Injury and Recovery in Diabetic Ischemic StrokeR01NS083559 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE · 2014 to 2018
$1.9M
Mechanisms of Vascular Protection after Acute StrokeR01NS063965 · NINDS · UNIVERSITY OF GEORGIA · PI FAGAN, SUSAN C · 2009 to 2013
$1.4M
Cerebral Arteriole Structure/Function in Diabetic Ischemic Brain InjuryI01BX000347 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI ERGUL, ADVIYE · 2009 to 2025
–
Mechanisms and Consequences of Hypertension after StrokeI01BX000891 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI FAGAN, SUSAN C · 2011 to 2014
–
BLRD VA I01 BX000347BLRD VA I01 BX000891NINDS NIH HHS R01 NS063965NINDS NIH HHS R01 NS083559
6 · The paper itself

Abstract

unlabelledIschemia/reperfusion and the resulting oxidative/nitrative stress impair cerebral myogenic tone via actin depolymerization. While it is known that NADPH oxidase (Nox) family is a major source of vascular oxidative stress; the extent and mechanisms by which Nox activation contributes to actin depolymerization, and equally important, the relative role of Nox isoforms in this response is not clear.

aimTo determine the role of Nox4 in hypoxia-mediated actin depolymerization and myogenic-tone impairment in cerebral vascular smooth muscle. MAIN

methodsControl and Nox4 deficient (siRNA knock-down) human brain vascular smooth muscle cells (HBVSMC) were exposed to 30-min hypoxia/45-min reoxygenation. Nox2, Nox4, inducible and neuronal nitric oxide synthase (iNOS and nNOS) and nitrotyrosine levels as well as F:G actin were determined. Myogenic-tone was measured using pressurized arteriography in middle cerebral artery isolated from rats subjected to sham, 30-min ischemia/45-min reperfusion or ex-vivo oxygen glucose deprivation in the presence and absence of Nox inhibitors.

resultsNox4 and iNOS expression were significantly upregulated following hypoxia or ischemia/reperfusion. Hypoxia augmented nitrotyrosine levels while reducing F actin. These effects were nullified by inhibiting nitration with epicatechin or pharmacological or molecular inhibition of Nox4. Ischemia/reperfusion impaired myogenic-tone, which was restored by the selective inhibition of Nox4.

conclusionNox4 activation in VSMCs contributes to actin depolymerization after hypoxia, which could be the underlying mechanism for myogenic-tone impairment following ischemia/reperfusion.

Indexed as

Actin CytoskeletonActinsAnimalsCells, CulturedHumansHypoxiaMembrane GlycoproteinsMiddle Cerebral ArteryMuscle, Smooth, VascularNADPH Oxidase 2NADPH Oxidase 4NADPH OxidasesNitric Oxide Synthase Type INitric Oxide Synthase Type IIRatsReperfusion Injury3-nitrotyrosineActinsCybb protein, ratMembrane GlycoproteinsNADPH Oxidase 2NADPH Oxidase 4NADPH OxidasesNitric Oxide Synthase Type INitric Oxide Synthase Type IINos2 protein, ratNox4 protein, ratRNA, Small InterferingTyrosineActin polymerizationHypoxiaIschemia/reperfusionMyogenic toneNADPH oxidaseNox4Oxidative stress

Identifiers

PMID27558234
PMCPMC5028312
OpenAlexW2507602253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.